Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors.
about
Poxvirus pathogenesisFrom scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancerThe epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus.Redundancy complicates the definition of essential genes for vaccinia virus.A whole-genome RNA interference screen for human cell factors affecting myxoma virus replicationConserved sequence homology of cysteine-rich regions in genes encoding glycoprotein A in Pneumocystis carinii derived from different host species.Chromosome mapping of Rmp-4, a gonad-dependent gene encoding host resistance to mousepox.Poxvirus-induced alteration of arachidonate metabolism.The tanapoxvirus 15L protein is a virus-encoded neuregulin that promotes viral replication in human endothelial cells.The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor.Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factorUnderstanding orthopoxvirus interference with host immune responses to inform novel vaccine design.Utilization of DNA recombination for the two-step replacement of growth factor sequences in the vaccinia virus genome.The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha.Deletion of the vaccinia virus growth factor gene reduces virus virulenceMultiple 3' ends of mRNA encoding vaccinia virus growth factor occur within a series of repeated sequences downstream of T clustersMapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alphaVaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors.Tanapoxvirus lacking a neuregulin-like gene regresses human melanoma tumors in nude mice.A role for vaccinia virus protein C16 in reprogramming cellular energy metabolism.The C11R gene, which encodes the vaccinia virus growth factor, is partially responsible for MVA-induced NF-κB and ERK2 activation.Vaccinia virus regulates expression of p21WAF1/Cip1 in A431 cells.The epidermal growth factor receptor is not a receptor for vaccinia virus.Stimulation of lymphokines in Jurkat cells persistently infected with vaccinia virus.The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication.Downregulation of the epidermal growth factor receptor by human cytomegalovirus infection in human fetal lung fibroblasts.A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication.M-T2: a poxvirus TNF receptor homologue with dual activities.A 34-kd protein with strong homology to ras-like proteins inhibits epidermal growth factor activity.Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts.ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease.Biochemical and functional analysis of smallpox growth factor (SPGF) and anti-SPGF monoclonal antibodies.Expression analysis of the TGF-β/SMAD target genes in adenocarcinoma of esophagogastric junction.The Host Factor Early Growth Response Gene (EGR-1) Regulates Vaccinia virus Infectivity during Infection of Starved Mouse Cells.Subversion of Cytokine Networks by Viruses
P2860
Q24634729-37755A83-0FEE-4FF4-AB8D-7FF5DDE3464EQ26822694-27D9FDEE-C1A0-489D-9019-52338B0F1E1CQ33734567-E3D15308-F156-431E-80C9-7AF143DCB00BQ33910501-1E2BAE0D-02C3-4329-9603-ED664B39FE24Q33930958-C734BB2A-A066-40F2-9350-E7A4175FDD2FQ34490252-20831F49-D26B-4627-BEAA-E51B1113B521Q34585582-C5854A2F-8969-48B1-9EAD-8C6F31E16F65Q35777995-1F569559-D884-42F6-9B36-CC64AECA33AEQ35850765-F254A969-833B-4397-BEFB-BCEE6176F9F3Q36147156-057D6105-CB70-404E-8D9B-1B9CB2C80F66Q36667899-717350A4-E089-4FB6-AE9B-AC9DD9CEC7B2Q36694749-33871A07-2382-4A5C-85B6-3559670DBA83Q36699676-7A2A3790-9F08-4ADA-A42C-1C46C59C6928Q36728801-36F36CA9-00DD-441A-8894-CE054F78D477Q36797598-CA9C1315-FBA4-46AA-976F-1C0FB9D2055EQ36834422-B9F81EE5-AF67-4F5C-95C7-D521AAE7B670Q36876074-FB1B8A61-BCB4-4E83-949B-DEE4C41EA962Q36884106-6585B028-522A-4B6F-A753-DF8839F251EEQ36886902-3E1D1A92-91C0-4212-AB81-2BFD47E5310BQ36909038-370BFFC0-6ECD-4D9D-A03C-981F0EC6F0F8Q38741265-6CD44315-716D-49A9-8F1D-2F609006834EQ38944394-663902D0-2CE2-4155-B370-60182116A158Q39323853-01823460-185B-4DC0-B813-CC3A1EF3ABB1Q39698568-DCFB9784-256E-4F40-9093-06341D1EB7A5Q40043247-21DB8BBB-918C-42F9-9C34-E6A7079B1C3CQ40308602-9BAF39DE-D5C5-4D72-B460-08E0295B14B7Q40577848-865CD198-E491-47C1-90D6-8E7D68EFC083Q40681979-D6597568-5414-46A8-AC3C-A435EB719138Q40791679-A646DBF0-52A8-47D3-8D5A-3B0600A0EC6EQ41300846-5ABD322A-6E52-4795-A10D-0005FB3ADD18Q41561510-40E6BD59-5934-40A2-8DA4-41FDEFA89CE3Q41989639-D5140C9C-B4C4-45C9-B20E-FEBE7690497EQ43248887-3C36876F-613C-4B2A-9B5A-B6913323605FQ44171115-2732FE4D-F69E-4A9F-9BE1-4345B763649EQ53394170-B56E15B0-6934-4C7C-A09B-9048B03BF32CQ54120212-BE41411E-09BC-4475-A436-41BFB20C7BEEQ58764105-2E6CE256-5B72-4AAF-B80F-762989B2D2E8
P2860
Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vaccinia virus-infected cells ...... and epidermal growth factors.
@en
Vaccinia virus-infected cells ...... and epidermal growth factors.
@nl
type
label
Vaccinia virus-infected cells ...... and epidermal growth factors.
@en
Vaccinia virus-infected cells ...... and epidermal growth factors.
@nl
prefLabel
Vaccinia virus-infected cells ...... and epidermal growth factors.
@en
Vaccinia virus-infected cells ...... and epidermal growth factors.
@nl
P2093
P2860
P356
P1476
Vaccinia virus-infected cells ...... and epidermal growth factors.
@en
P2093
P2860
P304
P356
10.1073/PNAS.82.16.5300
P407
P577
1985-08-01T00:00:00Z